GeneDx Holdings Corp. (WGS)
154.68
-3.89
(-2.45%)
USD |
NASDAQ |
Dec 11, 13:49
GeneDx Holdings EPS Diluted (Quarterly): -0.2651 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Illumina, Inc. | 0.974 |
| Labcorp Holdings, Inc. | 3.120 |
| Delcath Systems, Inc. | 0.0207 |
| Star Operating Cos., Inc. | 0.8643 |
| CytoSorbents Corp. | -0.0505 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.635M |
| Revenue (Quarterly) | 116.74M |
| Total Expenses (Quarterly) | 124.38M |
| Enterprise Value | 4.543B |
| Gross Profit Margin (Quarterly) | 68.04% |
| Profit Margin (Quarterly) | -6.54% |
| Earnings Yield | 0.04% |
| Operating Earnings Yield | 0.25% |
| Normalized Earnings Yield | 0.1258 |